Search
Searching Content indexed under Patent by McGuireWoods LLP ordered by Published Date Descending.
Links to Result pages
 
1 2  
>>Next
 
Title
Country
Organisation
Author
Date
1
AbbVie Requests Biosimilar Labeling Modification
On August 10, AbbVie, Inc. filed a supplement to its earlier filed Citizen Petition, levying another challenge to FDA's implementation of the Biologics Price Competition and Innovation Act (BPCIA).
United States
19 Aug 2015
2
IPR Broader Review Standard Upheld By Narrow Federal Circuit Majority
The PTAB is charged with rendering decisions on appeals from adverse examiner decisions, post-issuance challenges to patents, and interferences.
United States
17 Jul 2015
3
Abilify®'s Saga Continues: Otsuka's Eight-Day Streak Of Generic-Free Competition Ends, For Now
Abilify®'s blocking Patent No. 5,006,528 ("the '528 patent") expired on April 20, 2015, and Otsuka had already attempted to enjoin generic entry based on some of its other patents, but had so far been unsuccessful.
United States
2 Jun 2015
4
Supreme Court Alters Claim Construction Standard of Review
The Supreme Court explained that the Federal Circuit will "still review the district court's ultimate construction of the claim de novo" but that any underlying factual findings can be overturned only for "clear error."
United States
2 Feb 2015
5
Patent Infringement Lawsuit Reminds ERISA Fiduciaries To Monitor Service Providers
While the court’s dismissal with prejudice appears to put a stake in the heart of GRQ’s claim, the lawsuit is an important reminder of the fiduciary duty to carefully select and periodically monitor ERISA plan service providers.
United States
2 Feb 2015
6
European Competition Law Newsletter – January 2015
On 26 November 2014, the EU General Court (the EU’s second-highest court) upheld a EUR2.5 million fine imposed by the European Commission for obstructing an EC dawn raid.
European Union
12 Jan 2015
7
Supreme Court: Two-Step Test To Evaluate Patent Eligibility
The United States Supreme Court rendered a decision concerning the patent ineligibility of method claims drawn to an abstract idea.
United States
8 Jul 2014
8
Supreme Court: No Possible Liability For Induced Infringement If No Possible Liability For Direct Infringement
The Supreme Court rejected the precedent that it was possible to be liable for induced infringement even if no one could be held liable for direct infringement.
United States
9 Jun 2014
9
Supreme Court: Claims Invalid Unless Claim Scope Known With "Reasonable Certainty"
The United States Supreme Court raised the standard of definiteness that patent claims must satisfy in order to be upheld as valid.
United States
9 Jun 2014
10
Supreme Court Lowers Bar To Attorney Fees In Patent Cases
Yesterday, the United States Supreme Court handed down a ruling that could offer defendants some real relief from frivolous patent infringement lawsuits.
United States
6 May 2014
11
Protection From Infringement Allegations Under The ‘Kessler Doctrine’
Earlier this week, the Federal Circuit relied on the obscure Kessler Doctrine to prevent a patentee from asserting its patent in Brain Life v Eleckta.
United States
2 Apr 2014
12
New EU Antitrust Rules For Technology Licensing Agreements
On 21 March 2014, the European Commission adopted new rules governing technology transfer agreements under the EU antitrust rules.
European Union
1 Apr 2014
13
Sports Technology: Recent Patents And New Innovations
From golf balls to football blocking sleds, sports innovators have created better and safer sports equipment, improved and more precise performance measuring technologies, and superior and more effective training methodologies that have helped world-class athletes shatter world records.
United States
8 Jan 2014
14
Supreme Court Holds That Companies Can Patent cDNA Segments But Not Naturally Occurring DNA Segments
The Supreme Court unanimously held in Association for Molecular Pathology et al. v. Myriad Genetics, Inc. that a naturally occurring DNA segment is a product of nature and not patent eligible merely because a company has isolated the segment from the rest of the human genome.
United States
24 Jun 2013
15
Three Years On: The European Commission (Finally) Proceeds Against Patent Settlements
In July 2009, the European Commission (EC) published the results of its study into competition in the pharmaceutical sector in the EU.
European Union
10 Aug 2012
16
Protecting Your Technology In The EU
On Dec. 6, 2011, the European Commission (EC) started a consultation on the application of the EU competition law rules to "technology transfer agreements" (TTAs). TTA is the EC’s term for patent, know-how and software copyright licensing agreements, as well as similar agreements.
European Union
15 Dec 2011
17
Patent Reform Expected To Become Law
On September 8, Congress passed the Leahy-Smith America Invents Act.
United States
21 Sep 2011
18
European Commission's Second Report on Patent Settlements in the Pharmaceutical Sector in the EU
On July 6, 2011, the European Commission adopted its second report on the monitoring of patent settlements in the pharmaceutical sector in the EU.
European Union
3 Aug 2011
19
EU/UK Competition Law Newsletter - February 2011
The European Commission (EC) has addressed information requests to selected originator and generic pharmaceutical companies, asking them to submit copies of their patent settlement agreements concluded in the European Economic Area (EEA) in 2010.
UK
2 Feb 2011
20
Delaying Generic Drugs: The Legal Landscape Surrounding Reverse Payment Agreements To Protect Patent Holders
Settlement agreements involving reverse payments by pharmaceutical patent holders to delay the introduction of generic equivalents are receiving increased attention from all three branches of the federal government.
United States
1 Apr 2010
Links to Result pages
 
1 2  
>>Next